Serum Amyloid A: A Double-Edged Sword in Health and Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104528 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ailing Ji und 2 weiteren Autor:innen. Beteiligte Einrichtung: Saha Cardiovascular Research Center, University of Kentucky, 567 Charles T Wethington Building, 900 S. Limestone Street, Lexington, KY 40536-0200, US…. Hauptthemen laut MEDLINE: Serum Amyloid A Protein, Inflammation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institute of Health, National Institutes of Health.
Abstract (Originalsprache)
Despite more than fifty years since its discovery in the 1970s, Serum Amyloid A (SAA)’s true biological functions remain enigmatic. The research so far has primarily associated SAA with chronic inflammatory conditions such as cardiovascular disease, obesity, and type 2 diabetes; its role in acute inflammation is less understood. Unlike the modest elevations observed in chronic conditions, SAA levels surge dramatically during acute inflammatory responses. Notably, approximately 2.5% of hepatic protein synthesis is devoted to SAA production during acute inflammation—despite the high energy demands required for synthesizing pro-inflammatory cytokines and immune cell activation—leaving its precise necessity unclear. Elucidating SAA’s physiological role in acute inflammation is crucial to determine the therapeutic potential of SAA inhibition for chronic inflammatory diseases, such as atherosclerosis and abdominal aortic aneurysms. The evidence suggests that SAA may play a protective role in acute inflammation, positioning it as a “double-edged sword”: detrimental in chronic inflammation, yet potentially beneficial in acute settings. This review explores the divergent roles of SAA in chronic versus acute inflammation, proposing that while SAA inhibition could offer therapeutic benefits for chronic conditions, it might pose risks during acute inflammation. As the primary transporter of SAA in circulation, high-density lipoprotein (HDL) has been shown to become dysfunctional in chronic inflammation, at least partly due to SAA’s effects. However, we propose that SAA may confer functional properties to HDL during acute inflammatory states, such as sepsis, thereby highlighting the context-dependent nature of its impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Saha Cardiovascular Research Center, University of Kentucky, 567 Charles T Wethington Building, 900 S. Limestone Street, Lexington, KY 40536-0200, USA.
- Department of Internal Medicine, University of Kentucky, 567 Charles T Wethington Building, 900 S. Limestone Street, Lexington, KY 40536-0200, USA.
ORCID-Profile: Luke W Meredith, Preetha Shridas
Förderung
- NHLBI NIH HHS
- National Institute of Health
- National Institutes of Health
Zitieren
APA
Ji, A., Meredith, L. W., & Shridas, P. (2025). Serum Amyloid A: A Double-Edged Sword in Health and Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104528
Vancouver
Ji A, Meredith LW, Shridas P. Serum Amyloid A: A Double-Edged Sword in Health and Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104528
BibTeX
@article{Ji2025,
author = {Ji, Ailing and Meredith, Luke W and Shridas, Preetha},
title = {Serum Amyloid A: A Double-Edged Sword in Health and Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104528}
}
EUVIMED